These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25072849)

  • 1. Anti-HDV IgM as a marker of disease activity in hepatitis delta.
    Wranke A; Heidrich B; Ernst S; Calle Serrano B; Caruntu FA; Curescu MG; Yalcin K; Gürel S; Zeuzem S; Erhardt A; Lüth S; Papatheodoridis GV; Bremer B; Stift J; Grabowski J; Kirschner J; Port K; Cornberg M; Falk CS; Dienes HP; Hardtke S; Manns MP; Yurdaydin C; Wedemeyer H;
    PLoS One; 2014; 9(7):e101002. PubMed ID: 25072849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
    Mederacke I; Yurdaydin C; Dalekos GN; Bremer B; Erhardt A; Cakaloglu Y; Yalcin K; Gurel S; Zeuzem S; Zachou K; Bozkaya H; Dienes HP; Manns MP; Wedemeyer H;
    Antivir Ther; 2012; 17(2):305-12. PubMed ID: 22293066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short communication: evaluation of the correlation between hepatitis D virus (HDV) RNA positivity and HDV antibodies].
    Ozekinci T; Atmaca S; Akpolat N; Temiz H; Arikan E
    Mikrobiyol Bul; 2005 Jul; 39(3):345-9. PubMed ID: 16358495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
    Ricco G; Popa DC; Cavallone D; Iacob S; Salvati A; Tabacelia D; Oliveri F; Mascolo G; Bonino F; Yuan Q; Xia NS; Gheorghe L; Brunetto MR
    J Viral Hepat; 2018 Aug; 25(8):911-919. PubMed ID: 29577518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis D virus antibodies and liver function profile among patients with chronic hepatitis B infection in Abuja, Nigeria.
    Abdulkareem LO; Ndububa DA; Uhunmwangho AO; Yunusa T
    J Infect Dev Ctries; 2021 Jan; 15(1):141-146. PubMed ID: 33571156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serology of delta hepatitis and the detection of IgM anti-HD by EIA using serum derived delta antigen.
    Shattock AG; Morris M; Kinane K; Fagan C
    J Virol Methods; 1989 Mar; 23(3):233-40. PubMed ID: 2654168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of IgM anti-hepatitis D virus (HDV) in chronic HDV infection.
    Lau JY; Smith HM; Chaggar K; Hansen LJ; Portmann BC; Alexander GJ; Williams R
    J Med Virol; 1991 Apr; 33(4):273-6. PubMed ID: 1856706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
    Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
    J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.
    Liao B; Zhang F; Lin S; He H; Liu Y; Zhang J; Xu Y; Yi J; Chen Y; Liu H; Wang Z; Cai W
    PLoS One; 2014; 9(12):e115888. PubMed ID: 25532128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The analysis of hepatitis delta virus infective markers in the hepatitis is B virus infective people].
    Xu PS; Han SY; Sun CY; Zhao J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):307-9. PubMed ID: 23189853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
    Borghesio E; Rosina F; Smedile A; Lagget M; Niro MG; Marinucci G; Rizzetto M
    Hepatology; 1998 Mar; 27(3):873-6. PubMed ID: 9500721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis delta virus testing, epidemiology and management: a multicentre cross-sectional study of patients in London.
    El Bouzidi K; Elamin W; Kranzer K; Irish DN; Ferns B; Kennedy P; Rosenberg W; Dusheiko G; Sabin CA; Smith BC; Nastouli E
    J Clin Virol; 2015 May; 66():33-7. PubMed ID: 25866333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].
    Zheng RJ; Talafu T; Deng ZR; Han D; Pan KJ; Lu XB
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1044-1049. PubMed ID: 36727249
    [No Abstract]   [Full Text] [Related]  

  • 17. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
    Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
    Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.
    Couto I; Victoria M; Veloso VG; Rodrigues L; Grinsztejn B; Lacerda M; Victoria F; Perazzo H
    PLoS One; 2017; 12(3):e0174453. PubMed ID: 28329027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of IgM antibodies to delta antigen after coinfection and superinfection with the delta virus.
    Dimitrakakis M; Waters MJ; Wootton A; Gust I
    J Med Virol; 1986 Dec; 20(4):305-11. PubMed ID: 3794670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.